blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2129692

EP2129692 - ACTIVATION OF HUMAN ANTIGEN-PRESENTING CELLS THROUGH CLEC-6 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.12.2014
Database last updated on 07.10.2024
Most recent event   Tooltip19.12.2014Application deemed to be withdrawnpublished on 21.01.2015  [2015/04]
Applicant(s)For all designated states
Baylor Research Institute
Suite 125, 3434 Live Oak Street
Dallas, TX 75204 / US
[2009/50]
Inventor(s)01 / BANCHEREAU, Jacques, F.
6730 Northaven
Dallas, TX 75230 / US
02 / OH, Sangkon
45 Caterham Court
Baltimore, MD 21237 / US
03 / ZURAWSKI, Gerard
7620 Jordan Lane
Midlothian, TX 76065 / US
04 / ZURAWSKI, Sandra
7620 Jordan Lane
Midlothian, TX 76065 / US
05 / LI, Dapeng
6061 Village Bend 1004
Dallas, TX 75206 / US
 [2009/50]
Representative(s)SONN Patentanwälte GmbH & Co KG
Riemergasse 14
1010 Wien / AT
[N/P]
Former [2009/50]Sonn & Partner Patentanwälte
Riemergasse 14
1010 Wien / AT
Application number, filing date08743530.122.02.2008
[2009/50]
WO2008US54785
Priority number, dateUS20070891418P23.02.2007         Original published format: US 891418 P
[2009/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008103947
Date:28.08.2008
Language:EN
[2008/35]
Type: A2 Application without search report 
No.:EP2129692
Date:09.12.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 28.08.2008 takes the place of the publication of the European patent application.
[2009/50]
Search report(s)International search report - published on:US27.11.2008
(Supplementary) European search report - dispatched on:EP11.11.2010
ClassificationIPC:C07K17/14, A61P37/00
[2010/48]
CPC:
C07K16/2851 (EP,US); C07K17/14 (KR); A61K39/395 (KR);
A61P37/00 (EP); A61P37/04 (EP); C07K16/00 (KR);
C07K2317/56 (EP,US); C07K2317/74 (EP,US); C07K2317/75 (EP,US) (-)
Former IPC [2009/50]C07K17/14
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/50]
TitleGerman:AKTIVIERUNG VON ZELLEN MIT MENSCHLICHEN ANTIGENEN DURCH CLEC-6[2009/50]
English:ACTIVATION OF HUMAN ANTIGEN-PRESENTING CELLS THROUGH CLEC-6[2009/50]
French:ACTIVATION DE CELLULES HUMAINES PRESENTANT UN ANTIGENE PAR L'INTERMEDIAIRE DE CLEC-6[2009/50]
Entry into regional phase23.09.2009National basic fee paid 
23.09.2009Search fee paid 
23.09.2009Designation fee(s) paid 
23.09.2009Examination fee paid 
Examination procedure23.09.2009Examination requested  [2009/50]
31.03.2011Amendment by applicant (claims and/or description)
10.03.2014Despatch of a communication from the examining division (Time limit: M04)
22.07.2014Application deemed to be withdrawn, date of legal effect  [2015/04]
18.08.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/04]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.03.2014
Fees paidRenewal fee
23.02.2010Renewal fee patent year 03
28.02.2011Renewal fee patent year 04
09.02.2012Renewal fee patent year 05
13.02.2013Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
28.02.201407   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO03073827  (CORIXA CORP [US], et al) [X] 19* the whole document *;
 [I]  - ARCE IGNACIO ET AL, "The human C-type lectin CLECSF8 is a novel monocyte/macrophage endocytic receptor.", EUROPEAN JOURNAL OF IMMUNOLOGY, (200401), vol. 34, no. 1, ISSN 0014-2980, pages 210 - 220, XP002593589 [I] 9-11,17,18,20-23 * the whole document *

DOI:   http://dx.doi.org/10.1002/AJI.200324230
 [X]  - FLORNES L M ET AL, "Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE LNKD- DOI:10.1007/S00251-004-0714-X, (20041001), vol. 56, no. 7, ISSN 0093-7711, pages 506 - 517, XP002319046 [X] 9-11,17,18,20-23 * the whole document *

DOI:   http://dx.doi.org/10.1007/s00251-004-0714-x
 [A]  - BALCH S G ET AL, "CLONING OF A NOVEL C-TYPE LECTIN EXPRESSED BY MURINE MACROPHAGES", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US LNKD- DOI:10.1074/JBC.273.29.18656, (19980717), vol. 273, no. 29, ISSN 0021-9258, pages 18656 - 18664, XP002935413 [A] 1-28 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.273.29.18656
International search[A]US2006269949  (HALLORAN PHILIP F [CA]);
 [A]  - MA, "Genome-Wide Analysis of Human Peripheral Leukocyte Gene Expression", PHD THESIS, (2003), page 51, 60, XP008113922

DOI:   http://dx.doi.org/10.1002/ijc.20227
 [A]  - SCHAFT N. ET AL., "Dendritic cell vaccination and other strategies to tip the balance of the immune system", CANCER IMMUNOL. IMMUNOTHER., (2008), vol. 57, no. 6, pages 913 - 928, XP019586741
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.